| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 886,6 k € | -44.0% | 1,6 M € | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||
| Gross margin | 159,1 k € | -8.5% | 173,8 k € | +14.8% | 151,4 k € | -10.6% | 169,5 k € | -1.3% | 171,6 k € | +26.9% | 135,3 k € | -66.5% | 404,2 k € | +55.0% | 260,8 k € | -10.6% | 291,8 k € | +19.1% | 245,0 k € | -6.3% | 261,5 k € | +35.1% | 193,6 k € | -2.5% | 198,5 k € | +23.8% | 160,4 k € | -5.9% | 170,4 k € | -2.9% | 175,6 k € | +5.0% | 167,3 k € | +64.5% | 101,7 k € | +3.5% | 98,2 k € | |
| EBITDA | -19,2 k € | -149.1% | 39,1 k € | -25.2% | 52,2 k € | +42.9% | 36,5 k € | +40.2% | 26,1 k € | +1891.2% | 1,3 k € | -99.2% | 162,7 k € | +23.1% | 132,1 k € | +49.9% | 88,1 k € | +406.6% | 17,4 k € | -56.6% | 40,1 k € | +34.4% | 29,8 k € | -13.8% | 34,6 k € | +28.0% | 27,0 k € | -52.0% | 56,3 k € | -24.2% | 74,3 k € | -29.6% | 105,4 k € | +36.0% | 77,5 k € | -13.4% | 89,6 k € | |
| Operating profit | -44,3 k € | -418.8% | 13,9 k € | -48.4% | 26,9 k € | +260.7% | 7,5 k € | +132.5% | -23,0 k € | +60.3% | -57,8 k € | -158.4% | 99,0 k € | +11.5% | 88,8 k € | +49.8% | 59,3 k € | +617.4% | -11,5 k € | -217.2% | 9,8 k € | +183.9% | -11,7 k € | -64.2% | -7,1 k € | +55.5% | -16,0 k € | -168.1% | 23,4 k € | -41.7% | 40,2 k € | -45.0% | 73,0 k € | +62.8% | 44,9 k € | -18.8% | 55,3 k € | |
| Profit/loss | -44,2 k € | -22.8% | -36,0 k € | -293.6% | 18,6 k € | +3107.4% | -618,7 € | +98.2% | -33,7 k € | +49.1% | -66,2 k € | -224.4% | 53,2 k € | +3.8% | 51,2 k € | +32.7% | 38,6 k € | +217.6% | -32,8 k € | -103.8% | -16,1 k € | +59.4% | -39,6 k € | -2.5% | -38,7 k € | +12.0% | -44,0 k € | -2763.8% | -1,5 k € | -116.6% | 9,2 k € | -78.6% | 43,2 k € | +211.9% | 13,8 k € | -4.8% | 14,5 k € | |
| Equity | 9,1 k € | -82.9% | 53,3 k € | -40.3% | 89,4 k € | +0.7% | 88,8 k € | -0.7% | 89,4 k € | -27.4% | 123,0 k € | -35.0% | 189,2 k € | +39.1% | 136,0 k € | +60.4% | 84,8 k € | +83.6% | 46,2 k € | -41.5% | 79,0 k € | -16.9% | 95,1 k € | -29.4% | 134,7 k € | -22.3% | 173,4 k € | -20.2% | 217,4 k € | -0.7% | 218,9 k € | +4.4% | 209,7 k € | +1.5% | 206,5 k € | +1.7% | 203,0 k € | |
| Total assets | 346,4 k € | -12.5% | 396,1 k € | -22.3% | 509,6 k € | -6.3% | 543,8 k € | +42.5% | 381,6 k € | -10.0% | 423,9 k € | -21.7% | 541,2 k € | -14.6% | 633,7 k € | -27.4% | 873,2 k € | +5.7% | 826,2 k € | -8.8% | 906,3 k € | +0.0% | 905,9 k € | -2.9% | 932,9 k € | -3.2% | 964,1 k € | +2.9% | 936,6 k € | -0.5% | 941,5 k € | -11.2% | 1,1 M € | -1.3% | 1,1 M € | -1.1% | 1,1 M € | |
| Cash | 10,1 k € | +110.7% | 4,8 k € | -93.0% | 68,1 k € | -55.1% | 151,8 k € | +648.4% | 20,3 k € | +61.3% | 12,6 k € | -76.0% | 52,5 k € | -33.6% | 79,1 k € | +1225.3% | 6,0 k € | +91.2% | 3,1 k € | -72.7% | 11,4 k € | -11.4% | 12,9 k € | +363.0% | 2,8 k € | +721.8% | 339,0 € | -93.7% | 5,4 k € | -58.0% | 12,9 k € | +246.7% | 3,7 k € | -73.2% | 13,9 k € | +8.7% | 12,8 k € | |
| Debts | 337,1 k € | -1.6% | 342,7 k € | -18.4% | 420,1 k € | -7.6% | 454,7 k € | +56.0% | 291,5 k € | -3.1% | 300,9 k € | -14.5% | 352,0 k € | -26.6% | 479,7 k € | -39.1% | 787,3 k € | +3.0% | 764,2 k € | -6.0% | 813,1 k € | +1.7% | 799,1 k € | +2.0% | 783,7 k € | +0.5% | 780,2 k € | +8.7% | 717,9 k € | -0.4% | 721,0 k € | -15.2% | 850,1 k € | -1.8% | 865,7 k € | -1.7% | 880,9 k € | |
| Staff | 2,4 | 1,5 | 1,3 | 1,7 | 1,9 | 1,7 | — | 4,3 | 3,8 | 3,9 | 3,6 | 2,6 | 2,6 | 2,4 | 5 | 2,4 | 1,8 | 0,8 | 0,1 | |||||||||||||||||||
Public limited company · Genappe · incorporated on 05/09/2005 · 2,4 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+110.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE DES PAGODES is a Public limited company incorporated in 2005. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Genappe. It employs on average 2,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette